Avantor (AVTR) Total Non-Current Liabilities (2018 - 2026)
Avantor's (AVTR) quarterly Total Non-Current Liabilities came in at $5.7 billion in Q1 2026, down 2.84% year-on-year from $5.9 billion in Q1 2025, and down 2.64% quarter-over-quarter from $5.9 billion in Q4 2025.
Avantor (AVTR) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Avantor's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $5.7 billion for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 2.84% year-over-year to $5.7 billion in Q1 2026; TTM through Mar 2026 was $5.7 billion, a 2.84% decrease from a year earlier, with the FY2025 full-year figure at $5.9 billion, up 0.9% from the prior year.
- Total Non-Current Liabilities slipped to $5.7 billion in Q1 2026 per AVTR's latest filing, from $5.9 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $9.1 billion in Q1 2022 and bottomed at $5.7 billion in Q1 2026.
- The 5-year median for Total Non-Current Liabilities is $7.1 billion (2024), against an average of $7.1 billion.
- Across the five-year window, Total Non-Current Liabilities soared 38.98% in 2022 and decreased 21.31% in 2024, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $8.3 billion in 2022, then dropped by 11.35% to $7.4 billion in 2023, then slipped by 21.31% to $5.8 billion in 2024, then increased by 0.9% to $5.9 billion in 2025, then dropped by 2.64% to $5.7 billion in 2026.
- Per Business Quant, the three latest AVTR Total Non-Current Liabilities figures stand at $5.7 billion (Q1 2026), $5.9 billion (Q4 2025), and $5.7 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | 5.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.70 Bn |
| Dec 31, 2025 | 5.85 Bn |
| Sep 30, 2025 | 5.70 Bn |
| Jun 30, 2025 | 6.10 Bn |
| Mar 31, 2025 | 5.86 Bn |
| Dec 31, 2024 | 5.80 Bn |
| Sep 30, 2024 | 6.87 Bn |
| Jun 30, 2024 | 6.90 Bn |
| Mar 31, 2024 | 7.07 Bn |
| Dec 31, 2023 | 7.37 Bn |
| Sep 30, 2023 | 7.43 Bn |
| Jun 30, 2023 | 7.78 Bn |
| Mar 31, 2023 | 8.10 Bn |
| Dec 31, 2022 | 8.31 Bn |
| Sep 30, 2022 | 8.19 Bn |
| Jun 30, 2022 | 8.61 Bn |
| Mar 31, 2022 | 9.12 Bn |
| Dec 31, 2021 | 9.34 Bn |
| Sep 30, 2021 | 7.69 Bn |
| Jun 30, 2021 | 7.85 Bn |